Press Releases

HOUSTON, March 2, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today reported financial results for the fourth quarter and full year end

NEW YORK, March 2, 2020 /PRNewswire/ -- The continued worldwide spread of COVID-19 (the coronavirus disease) may weaken the U.S. dollar over the long run by impelling multinational corporates and foreign investors in the United States to repatriate money back to their home countries, said Kuniyuki Hirai

NEW YORK, March 2, 2020 /PRNewswire/ -- Marking its one-year anniversary, New York trial boutique Mukasey Frenchman & Sklaroff LLP

DALLAS, March 2, 2020 /PRNewswire/ -- #stayfactual. There is a lot of misinformation out there regarding coronavirus – some intentional, some unintentional. It is important that people take care to separate fact from fiction.

FORT LAUDERDALE, Fla., March 2, 2020 /PRNewswire/ -- Q'STRAINT, a recognized global leader of mobility passenger safety solutions, announce the release of the QUANTUM GEN II, a continua

WASHINGTON and TEANECK, N.J., March 2, 2020 /PRNewswire/ -- Medicomp Systems, the leading provider of clinician-driven, point-of-care solutions that fix EHRs, and Holy Name Health, a comprehensive 361-bed acute care facility providing compassionate and personalized care, today announced the unveiling of Harmony EHR, a new solution d

ALEXANDRIA, Va., March 2, 2020 /PRNewswire/ -- The US Army has mandated that all soldiers (nurses, engineers, etc.) be able to pass the Army Combat Fitness Test by October 2020.  There are no special accommodations for women, nor are there any exceptions for soldiers in their 50s and 60s.

BRIDGEWATER, N.J., March 2, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Sarclisa® (isatuximab-irfc) in combination with pomalidomide and dexamethasone (pom-dex) for the treatment of adults with relapsed refractory multiple myeloma (RRMM) who have received at least two prior therapies including lenalidomide and a proteasom

NEW YORK, March 2, 2020 /PRNewswire/ -- Renalytix AI plc (AIM: RENX), a developer of artificial intelligence enabled clinical diagnostics for kidney disease, announces it will be presenting

WASHINGTON, March 2, 2020 /PRNewswire/ -- LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit organization, announced today that Jeanne Regnante, a long-time healthcare and global patient engagement professional, has joined the Foundation as Chief Health Equity and Diversity Officer.